FDA Slaps Embolization Device With Class I Recall After Deaths Increased bowel ischemia risk when Obsidio Embolic is used for lower GI bleeds Apr 17, 2024
Deeper Sedation During Colonoscopy Linked to Improved Detection of Serrated Polyps Propofol boosts serrated polyp detection by 50%, little difference for all neoplasia, adenomas Apr 17, 2024
Immunotherapy During Pregnancy Just as Safe as Other Cancer Drugs However, use should be avoided "if possible" due to risk of rare immune-related adverse events Apr 17, 2024
Could Francis Collins's Prostate Cancer Story Deter Men From Active Surveillance? Experts suggest his apparent situation is rare Apr 17, 2024
Roundup Maker Seeks Lawmakers' Help to Squelch Claims It Failed to Warn About Cancer Legal experts say legislation could provide immunity from lawsuits Apr 16, 2024
Automated, Personalized Outreach Boosts CRC Screening in Diverse Patient Population Absolute improvement of 30-40% in screening participation after 1 year Apr 16, 2024
Many With Breast Cancer 'Systematically Left Behind,' Report Says Lancet Commission issues recommendations to address inequities in global breast cancer care Apr 15, 2024
Don't Rule Out Breast Cancer Surgery for 90-Year-Olds Retrospective study suggests survival benefit over conservative management Apr 15, 2024
What Kate Middleton Reminds Us About the Role of Privacy in Healing Everyone deserves the "sanctity of space" during a course of illness Apr 15, 2024
Cryoablation for Early-Stage Breast Cancer a Safe Option in Older Women Breast cancer survival rate was 97% at 5 years Apr 15, 2024
Journey Into Virtual Reality Eases Cancer Pain VR distraction therapy could be a useful non-pharmacologic alternative, study suggests Apr 12, 2024
Possible New Standard for Treated Advanced CRC With KRAS Mutations Adagrasib plus cetuximab leads to responses in one-third of patients, median OS of 15.9 months Apr 12, 2024
'I'm Dying, You're Not': Terminally Ill Ask More States for Physician-Assisted Death Debates on medical aid in dying bills are playing out in Kentucky, Delaware, Maryland, and Iowa Apr 12, 2024
Francis Collins Discloses His 'Aggressive' Prostate Cancer Diagnosis Former NIH director said he went public to "share lifesaving information" Apr 12, 2024
Riding the 'Boob Bus'; Prior Authorization Pushback; Cancer Warning for Alcohol? News, features, and commentary about cancer-related issues Apr 12, 2024
1,000 Paper Cranes Can Bring Our Patients One Step Closer to Healing We must remind our patients to hold on to hope Apr 11, 2024
O.J. Simpson Dies After Cancer Battle Football star who was acquitted of murders but later found liable in civil trial dead at 76 Apr 11, 2024
Neoadjuvant Chemo-IO Promising in Borderline Resectable Pancreatic Cancer Combination associated with favorable R0 resection and survival rates Apr 10, 2024
Study Assuages Thyroid Cancer Fears With GLP-1 Receptor Agonists Study findings support conclusions of the European Medicines Agency's recent investigation Apr 10, 2024
Bispecific Checkpoint Inhibitor Improves Survival in Advanced Gastric/GEJ Cancer Almost 50% improvement in median survival, but against a suboptimal control regimen Apr 10, 2024
Immunotherapy After Definitive Therapy Flops in Head and Neck Cancer No event-free survival benefit with atezolizumab versus placebo in phase III trial Apr 10, 2024
Biden Admin Imposes National Limits on 'Forever Chemicals' in Drinking Water Most important action the EPA has ever taken on PFAS, says agency administrator Apr 10, 2024
Cancer Warnings on Booze; Rats, Roaches in Hospitals; Barefoot Pharma Workers Health news and commentary from around the Web gathered by 51˶ staff Apr 10, 2024
Why Aren't Some Women Getting Screening Mammograms? Social Factors May Be to Blame Cost concerns, lack of transportation, and social isolation may all contribute, CDC study finds Apr 09, 2024
Accelerated Aging Linked to Recent Increase in Early-Onset Solid Tumors Strength of association increased in more recent birth cohorts Apr 09, 2024
Novel PARP1 Inhibitor Shows Promise in Breast Cancer The drug had favorable safety compared with first-generation PARP inhibitors in phase I/II study Apr 09, 2024
FDA Approves Earlier Use of CAR-T Products for Myeloma Carvykti and Abecma move to second- and third-line, respectively Apr 08, 2024
High Response Rate in R/R Multiple Myeloma With Bispecific Antibody ORR of 71% that deepened over time and favorable safety profile with linvoseltamab Apr 08, 2024
Can Late-Stage Cancer Incidence Serve as an Endpoint for Screening Trials? Study shows it may be an alternative to cancer-specific mortality for some cancers, but not all Apr 08, 2024
Most Cancer Drugs Granted Accelerated Approval Fail Confirmatory Trials Only 43% showed clinical benefit within 5 years Apr 08, 2024
PSA and Biomarker Testing Plus MRI Appears to Improve Prostate Cancer Screening Early results suggest approach reduces overdiagnosis while better detecting high-grade cancer Apr 06, 2024
Bracing for a Surge in Prostate Cancer Diagnoses Report: Demographic changes will lead to a doubling of cases, 85% increase in mortality by 2040 Apr 05, 2024
Enhertu Gets Tumor-Agnostic FDA Approval for HER2-Positive Cancers About half of patients responded, duration of response as long as 19 months in three trials Apr 05, 2024
Cancer 'Tidal Wave' Forecast; Not Decaf, Too! Cautionary Tales of Cancer, Cannabis News, features, and commentary about cancer-related issues Apr 05, 2024
Incorporating Bereavement Into the Continuum of Care "Poor cousin of palliative care" needs more resources, buy-in, and normalization Apr 04, 2024
Chemotherapy/ICI Combos Falter as Second-Line Treatment for Gastric Cancer FOLFIRI plus durvalumab, with or without tremelimumab, no help after first-line chemotherapy Apr 04, 2024
Factor D Inhibitor Wins Approval for PNH With Extravascular Hemolysis Danicopan significantly improved hemoglobin at 12 weeks when added to a C5 inhibitor Apr 04, 2024
FDA OKs Injectable Antibiotic for Three Different Uses Ceftobiprole was at least comparable to currently used medications in studies Apr 03, 2024
Evidence Strengthens for De-Escalating Axillary Surgery in Breast Cancer Trial suggests axillary dissection can be avoided in some patients with early breast cancer Apr 03, 2024
Patient Stabs ED Worker; Campus Building Tied to Cancer; Your Gut and Heart Disease Health news and commentary from around the Web gathered by 51˶ staff Apr 03, 2024
